Released Jul 20, 2023, after the close
10-Q filed Jul 24, 2023, 24 days after period end · 0001035267-23-000159
Q2 2023 · 10-Q
Revenue$1.76B$1.76B +15.4% vs Q2 2022+3.5% vs Q1 2023
Net Income$420.80M$420.80M +36.7% vs Q2 2022+18.4% vs Q1 2023
EPS Diluted$1.18$1.18 +38.8% vs Q2 2022+18.0% vs Q1 2023
Gross Profit$1,171,900,000+14.5%
Operating Income$463,200,000+16.5%
Operating Cash Flowderived$665,700,000+49.0%
Free Cash Flowderived$487,400,000+54.1%
Margins · derived
Gross margin66.7%−0.5 pt vs Q2 2022
Operating margin26.4%+0.3 pt vs Q2 2022
Net margin24.0%+3.7 pt vs Q2 2022
What the release said
The release
Same quarter
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $1.76B | $1.52B | $1.46B | $852.10M |
| Net Income | $420.80M | $307.80M | $517.20M | $68.00M |
| EPS Diluted | $1.18 | $0.85 | $1.42 | $0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR